MARKET

LFCR

LFCR

Lifecore Biomedical Inc
NASDAQ
7.26
+0.03
+0.41%
Opening 15:05 12/06 EST
OPEN
7.21
PREV CLOSE
7.23
HIGH
7.32
LOW
7.20
VOLUME
46.75K
TURNOVER
0
52 WEEK HIGH
11.46
52 WEEK LOW
1.520
MARKET CAP
214.26M
P/E (TTM)
-2.1283
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at LFCR last week (1127-1201)?
Weekly Report · 2d ago
Weekly Report: what happened at LFCR last week (1120-1124)?
Weekly Report · 11/27 09:19
Lifecore Biomedical Inc: Current report
Press release · 11/20 22:12
Lifecore Biomedical, Inc. Reaches Favorable Resolution Regarding Previously-Disclosed Investigation Of Formerly-Held Subsidiary Yucatan Foods; Lifecore Has Agreed To Pay Disgorgement In The Amount Of $406,505
The u.s. Department of justice has declined to prosecute the company for violations of the foreign corrupt practices act. Lifecore has agreed to pay disgorgement in the amount of $406,505. The company's formerly-held subsidiary, yucatan foods l.p.
Benzinga · 11/20 21:21
Weekly Report: what happened at LFCR last week (1113-1117)?
Weekly Report · 11/20 09:19
Lifecore Biomedical Avoids U.S. Prosecution Over Alleged Mexico Bribes
Lifecore biomedical allegedly paid bribes to mexican government officials. The justice department says the company reported the misconduct within hours of learning of the alleged wrongdoing. Prosecutors say lifecore agreed to give up about $407,000 in costs it avoided by not paying bribes. The company won't face charges over the alleged bribery.
The Wall Street Journal · 11/17 23:04
Weekly Report: what happened at LFCR last week (1106-1110)?
Weekly Report · 11/13 09:18
Vanda Pharmaceuticals (VNDA) Reports Break-Even Earnings for Q3
NASDAQ · 11/08 22:25
More
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company and its subsidiaries design, develop, manufacture, and sell differentiated products for food and biomaterials markets, and license technology applications to partners. The Company specializes in specialty formulation, aseptic filling, and final packaging of both complex medical devices and injectable pharmaceuticals. It manufactures commercial products at its three cGMP facilities. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form as well as formulated and filled syringes and vials for injectable products used in treating a broad spectrum of medical conditions and procedures. It sells products utilizing hyaluronan that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets.

Webull offers Lifecore Biomedical Inc stock information, including NASDAQ: LFCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LFCR stock methods without spending real money on the virtual paper trading platform.